Decheng Capital LLC Beyond Spring Inc. Transaction History
Decheng Capital LLC
- $466 Billion
- Q4 2024
A detailed history of Decheng Capital LLC transactions in Beyond Spring Inc. stock. As of the latest transaction made, Decheng Capital LLC holds 4,882,651 shares of BYSI stock, worth $7.76 Million. This represents 1.71% of its overall portfolio holdings.
Number of Shares
4,882,651
Previous 4,958,143
1.52%
Holding current value
$7.76 Million
Previous $11.4 Billion
29.9%
% of portfolio
1.71%
Previous 2.69%
Shares
2 transactions
Others Institutions Holding BYSI
# of Institutions
19Shares Held
5.26MCall Options Held
12.1KPut Options Held
0-
Black Rock Inc. New York, NY215KShares$342,4140.0% of portfolio
-
Ubs Group Ag58.1KShares$92,3640.0% of portfolio
-
Tanaka Capital Management Inc New York, NY29.5KShares$46,8620.11% of portfolio
-
Geode Capital Management, LLC Boston, MA24.4KShares$38,7450.0% of portfolio
-
Northern Trust Corp Chicago, IL16.7KShares$26,5600.0% of portfolio
About BeyondSpring Inc.
- Ticker BYSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,928,900
- Market Cap $61.9M
- Description
- BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...